On Friday, January 26, the US Food and Drug Administration (FDA)—the agency charged with protecting public health via oversight of food, drugs, and medical devices—issued a statement about its decision to terminate a nicotine research project at the National Center for Toxicology Research (NCTR). The research had been the focus of campaign by an anti-animal … Continue reading FDA announcement regarding termination of primate study leaves many questions unanswered
The FDA Commissioner, Scott Gottlieb, made a statement last week that claimed animal welfare concerns had led to his agency’s decision to end a primate research project aimed at better understanding nicotine addiction in adolescents. However, details revealed in the project documents that were also released by the agency last week raise doubts about the … Continue reading The Curious Case of Catheter Removals at the FDA
The US Food and Drug Administration (FDA) announced yesterday that it terminated a study investigating the effects of nicotine in monkeys. This announcement, which was accompanied by the release of many records and documents related to the animals’ care, is troubling for many reasons. Among them, it again raises questions about oversight and decision-making. Nicotine … Continue reading Response to FDA statement on termination of a primate nicotine research study
The American Psychological Association has warned that the FDA may be winding down its own primate study, despite having started-- but not completed, nor made public-- an independent FDA review process. Why the FDA would stop the study before any report has been published will lead many into further questioning the influence that certain animal … Continue reading Is the FDA undermining its own study and the experts it sent to review it?
On September 25, 2017, Dr. Scott Gottlieb , Commissioner of the U.S. Food & Drug Administration (FDA) replied to a scathing letter from Dr. Jane Goodall, where Goodall denounced what she called the “cruel and unnecessary nicotine addiction experiments on monkeys”. We previously evaluated that letter from Goodall and now do the same with Commissioner Gottlieb’s letter. … Continue reading FDA response to Goodall letter found lacking
For immediate release Speaking of Research response to FDA announcement regarding nicotine research Late on September 25, as reported by the Washington Post, the US Food and Drug Administration (FDA) made the startling announcement that it has suspended a nicotine research project involving non-human primates; the goal of this research is to build a better … Continue reading Speaking of Research response to FDA announcement regarding nicotine research
This open letter is from scientists and leaders in the addiction research community. If you'd like to join the signatories listed below, please do in comments at the bottom of this article. Please also share with others with an interest in research on addiction. Smoking – and nicotine addiction – are sometimes easy targets for … Continue reading Jane Goodall and White Coat Waste are wrong about nicotine addiction research
On September 7, 2017, Dr. Jane Goodall wrote a scathing letter to Dr. Scott Gottlieb, Commissioner of the U.S. Food & Drug Administration (FDA) denouncing what she called the “cruel and unnecessary nicotine addiction experiments on monkeys” occurring there. The letter, which relies on the repeated use of opinion versus fact-based arguments by Goodall, is … Continue reading The Problem With Jane Goodall’s “Expert” Opinion